4
Changes in Ownership
Nautilus Biotechnology, Inc. Filed Acc 0001797672-26-000004
Options or other derivatives
- Director acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Akinsanya Karen Director | 2026-06-18 | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | D: show line 1 in the form |
Loading xslF345X06/wk-form4_1782159237.xml…